Skip to main content

Camp4 Therapeutics Corp(CAMP-Q)
NASDAQ

Today's Change
Real-Time Last Update Last Sale Cboe BZX Real-Time

Camp4 Therapeutics Corp

ONE KENDALL SQUARE BUILDING 1400 WEST 3RD FLOOR
CAMBRIDGE MA 02139 USA
P: 617-651-8867
http://www.camp4tx.com

Sectors & Indices

Sector
Industry
Employees

Profile

CAMP4 Therapeutics Corporation is a clinical-stage biotechnology company developing a pipeline of regulatory RNA-targeting therapeutics designed to upregulate gene expression with the goal of restoring healthy protein levels across a range of genetic diseases. CAMP4 Therapeutics Corporation is based in CAMBRIDGE, Mass.

Key Executives

NameTitle
Steven H. HoltzmanDirector
Daniel TardiffChief Scientific Officer

More from The Globe

The most oversold and overbought stocks on the TSX
The Bay Street Financial District is shown with the Canadian flag in Toronto on Friday, August 5, 2022.
Monday’s analyst upgrades and downgrades
A Dollarama store is seen Tuesday, June 11, 2013 in Montreal. Dollarama Inc. raised its quarterly dividend by 10 per cent as it reported its fourth-quarter profit and sales rose compared with a year ago. THE CANADIAN PRESS/Paul Chiasson
opinion
Why are Canadian bank valuations so low?
Tom Bradley
number cruncher
Eleven U.S. semiconductor stocks showing strength
For Number Cruncher column in Globe Investor/ROB only.
Wednesday’s analyst upgrades and downgrades
An office building for Goeasy Ltd, a personal lender for subprime borrowers, in Mississauga, Ontario, on March 10, 2026.
Bullish on Archer-Daniels-Midland Co.
Monica Rizk
Constellation ‘well-positioned’ to tackle AI disruption in software industry, company president says
In this photo illustration, a mobile phone with the logo of Canadian company Constellation Software Inc. is seen in front of business website.
number cruncher
Eight telecom stocks to watch during volatile times
For Number Cruncher column in Globe Investor/ROB only.

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2026.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).

Financial data provided by Zacks Investment Research.